FDA expected to OK Pfizer vaccine for kids ages 12-15 by next week
WASHINGTON (AP) — The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for kids ages 12 to 15 by next week, setting up shots for many before the beginning of the next school year.
That's according to a federal official and a person familiar with the process.
The FDA action would be followed by a meeting of a federal vaccine advisory committee to discuss whether to recommend the shot for 12-to 15-year-olds.
Then the Centers for Disease Control and Prevention would act on the committee's recommendation.
Those steps could be completed in a matter of days.